Cogent Biosciences, Inc.’s COGT share price has surged by 7.47%, which has investors questioning if this is right time to sell.

Cogent Biosciences, Inc.’s COGT share price has dipped by 9.08%, which has investors questioning if this is right time to buy ...

Cogent Biosciences, Inc. topline results for phase 2/3 studies on bezuclastinib targeting systemic mastocytosis & GIST are ...

Shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report) have received an average rating of “Moderate Buy” from the ...

A data center owned by Cogent Communications is up for sale in Hawaii. Via Crexi, Hawaii Commercial Real Estate is listing 96-1402 Waihona Place in Pearl City, O‘ahu island, as available. The site is ...

Session Date and Time: April 30, 2025 - 9:00 AM - 12:00 PM CT (10:00 AM - 1:00 PM ET) Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Cogent also announced today that the Compensation Committee ...

Funding will enable lead candidates CTX114 and CTX203 for AMD to enter clinical trials in the next year JERSEY CITY, N.J.--(BUSINESS WIRE)--#AMD--Character Biosciences, a precision medicine company ...

WALTHAM, Mass. and BOULDER, Colo., March 25, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined ...

WALTHAM, Mass. and BOULDER, Colo., March 25, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically ...